Executives And Founders Of Uber, Facebook And Apple Are Bullish On This Wellness App — You Can Coinvest At $1.15 Per Share

Dernières nouvelles pour Aura Biosciences (NASDAQ:AURA) Stock

AURA BIOSCIENCES INC

Aura Biosciences

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Aura Biosciences Inc

Aura Energy Ltd

Aura Fat Projects Acquisition Corp Ordinary Shares - Class A

Aura Fat Projects Acquisition Corp

Aura Fat Projects Acquisition Corp Units (1 Ord Class A & 1 War)

Aura Fat Projects Acquisition Corp Warrants(31/03/2027)

Aura Minerals Inc

Aura Systems Inc

AuraSource Inc

AURANIA RESOURCES ORD by Aurania Resources, Ltd.

Aurania Resources Ltd

Aurania Resources Ltd Warrants (21/10/2026)

Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) has been one of the most volatile AI stocks this year. After surging nearly 400% in 2024, the stock has struggled in recent months, dropping 25% from its all-time high <a href="https://www.benzinga.com/quote/PLTR">reached in mid-February. </a>
What To Know: Palantir has benefited from growing demand for its AI-powered data analytics platforms, particularly among government agencies and large enterprises. The company's revenue growth remains strong, with management projecting a 36% increase in the first quarter. However, some analysts believe this estimate may be conservative, as Palantir has a track record of setting expectations lower to deliver consistent revenue beats.
Even with this growth, Palantir's stock price has been a point of concern. The stock currently trades at a price-to-sales (P/S) ratio of 77, a level that requires extreme revenue acceleration to justify. For comparison, most software companies trade between 10 and 20 times sales. At its current valuation, Palantir would need to triple its revenue annually to maintain its stock price, an unlikely scenario given its current growth trajectory.
Ai Outlook: The AI investment landscape is also shifting. While businesses continue to integrate AI solutions, spending trends are becoming more scrutinized. 
Investors who piled into Palantir during last year's AI boom are now questioning whether the company can sustain its momentum. If revenue growth falls short or macroeconomic headwinds intensify, Palantir's stock could see further downside.
Market Overview: Market-wide weakness in high-growth tech stocks has also weighed on Palantir. Other AI-related names, including C3.ai (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) and Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), have seen similar pullbacks, reflecting broader concerns about valuations in the sector. While Palantir remains a leader in AI-driven analytics, its current stock price leaves little room for error.
The next few quarters may be crucial in determining whether Palantir can justify its high valuation. If the company continues to beat growth expectations and expand its commercial customer base, investor confidence may stabilize. However, if growth stalls or macroeconomic risks intensify, the stock could remain under pressure.
PLTR Price Action: Palantir shares closed up 3.27% at $87.45 at publication Wednesday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="1024" height="536" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02154248/Screenshot-2025-04-02-at-15.42.13-1024x536.png" alt="" class="wp-image-854115" style="width:343px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02154248/Screenshot-2025-04-02-at-15.42.13-1024x536.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02154248/Screenshot-2025-04-02-at-15.42.13-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02154248/Screenshot-2025-04-02-at-15.42.13-768x402.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02154248/Screenshot-2025-04-02-at-15.42.13-1536x804.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02154248/Screenshot-2025-04-02-at-15.42.13.png 1544w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44613907/tariff-shock-incoming-as-trump-prepares-sweeping-trade-duties-what-traders-need-to-know">Trump&#8217;s &#8216;Liberation Day&#8217; Tariff Reveal Set For 4 PM: What&#8217;s At Stake</a></li>
</ul>
Photo: Shutterstock.

News

Movers

Tech

PLTR

SNOW

Palantir Stock Drops As Valuation Concerns Grow: What You Need To Know (Updated)

Macro Economic Events

Econ #s

Economics

Trump: To Foreign Leaders I Say Terminate Your Own Tariffs; Start Buying American Goods; Tariffs Will Give Us Growth

Top Win International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOPW#NASDAQ">TOPW</a>) stock had a volatile Wednesday on its first trading day after pricing its initial public <a href="https://www.benzinga.com/25/03/44337072/digital-physical-therapy-company-hinge-health-seeks-to-raise-around-500-million-via-initial-public-offering">offering at $4 per share. </a>
What To Know: The Hong Kong-based luxury watch distributor announced the pricing of its IPO, offering 2,664,000 ordinary shares, raising approximately $10.6 million before underwriting discounts and expenses. The stock began trading on April 2, 2025, on the Nasdaq Capital Market under the ticker symbol &#8220;TOPW.&#8221;
The offering is expected to close on April 3, 2025, pending standard closing conditions. Underwriters have been granted a 45-day option to purchase an additional 399,600 shares at the IPO price, potentially increasing the total funds raised. Dominari Securities LLC is acting as the lead underwriter, with Revere Securities LLC as the co-underwriter.
Top Win plans to use the net proceeds to expand brand marketing, grow its sales team across Southeast Asia, diversify its inventory and for general corporate purposes. The company specializes in the trading, distribution and retail of international luxury watches, operating in a highly competitive market.
Despite the early price increase, investors will be watching how the company executes its growth strategy and whether demand for luxury watches remains strong. The stock's movement in the coming days will provide a clearer picture of investor sentiment following its debut on the public markets.
TOPW Price Action: Top Win shares closed down 4.25% at $3.83 at publication Wednesday, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="1024" height="528" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02161947/Screenshot-2025-04-02-at-16.19.25-1024x528.png" alt="" class="wp-image-854180" style="width:389px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02161947/Screenshot-2025-04-02-at-16.19.25-1024x528.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02161947/Screenshot-2025-04-02-at-16.19.25-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02161947/Screenshot-2025-04-02-at-16.19.25-768x396.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02161947/Screenshot-2025-04-02-at-16.19.25.png 1532w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44613907/tariff-shock-incoming-as-trump-prepares-sweeping-trade-duties-what-traders-need-to-know">Trump&#8217;s &#8216;Liberation Day&#8217; Tariff Reveal Set For 4 PM: What&#8217;s At Stake</a></li>
</ul>
Image Via Shutterstock.

Global

TOPW

What's Going On With Top Win International Shares Today?

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkarman-sd.com%2F&amp;esheet=54232754&amp;newsitemid=20250402394162&amp;lan=en-US&amp;anchor=Karman+Space+%26amp%3B+Defense&amp;index=1&amp;md5=3195f5ee193db3d26b78a435e9000a88">Karman Space &amp; Defense</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRMN#NYSE">KRMN</a>) ("Karman" or "the Company"), a leader in the design, testing, volume manufacturing, and sale of highly engineered, mission-critical subsystems for advanced missile, uncrewed aircraft, and space systems, today announced the grand opening of a new and purpose-built clean room, designed for the integration of lunar landers, spacecraft, habitat modules and satellites, at its Washington facility. Building on a decades long successful track record supporting major space programs, this investment strengthens Karman's ability to provide turn-key assembly, integration, and testing of state-of-the-art space vehicle systems and habitats at the fast pace required by the growing space industry.

KRMN

Karman Space & Defense Opens New ISO 8 Clean Room For Spacecraft Assembly And Integration

Politics

General

President Trump Says U.S. To Apply 10% Tariff On Imports From Brazil

The objective of the share consolidation is to enable the Company to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on Nasdaq.

Stock Split

LGCB

Linkage Global Plans 10 For 1 Share Consolidation

The S&amp;P 500 Index just finished a vicious <a href="https://www.benzinga.com/topic/s-p-500">first quarter of 2025</a>.
The stock market index lost over 4.5% as investor sentiment, as indicated by the CNN Money Fear and Greed Index, languishes in the <a href="https://www.benzinga.com/25/04/44601155/sp-500-settles-higher-ahead-of-tariff-day-fear-greed-index-remains-in-extreme-fear-zone">&#8220;Extreme Fear&#8221; category</a>. 
The widely held SPX fell into correction territory earlier this week, indicating a 10% drop from its recent high, before regaining some ground.
Also Read: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/03/44547975/sticky-inflation-weighs-on-markets-spy-qqq-tech-stocks-take-a-hit">Sticky Inflation Weighs On Markets — SPY, QQQ, Tech Stocks Take A Hit</a>
As one of the most widely used proxies for the SPX, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 3.76% this year as of writing. However, <a href="https://www.benzinga.com/etfs">in the ETF</a>, some stocks defied the trend:
<ul>
<li>CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) jumped 53.35% due to robust earnings growth in the last quarter. </li>
<li>Gold miner Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) rose 26.21%, and </li>
<li>Philip Morris International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) spiked 29% as it shifted its focus to smoke-free products.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/trading-ideas/25/04/44597684/exclusive-marchs-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-nvidia-apple-applovin-stock-rank">EXCLUSIVE &#8211; March&#8217;s 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?</a>
Markets are gearing up for even more turbulence as President Donald Trump unveiled a comprehensive slate of tariffs. Watch the stream below.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#x1f534;WATCH LIVE: Trump Speaks Live From The White House on Liberation Day &#x7C; April 2nd, 2025" width="500" height="281" src="https://www.youtube.com/embed/wgmKYg-zK9o?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Investors worry that these tariffs, potentially imposed widely on trading partners from China to Mexico and Canada, will raise costs, restrict consumer purchases, and temper economic growth. 
With economic news, Federal Reserve actions, and geopolitical tensions front and center, the SPX continues on uncertain footing. 
Investors will closely monitor how the market responds to Trump&#8217;s tariff declaration and whether defensive sectors continue to outperform in an increasingly uncertain economic climate.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44613351/chipotles-stock-is-sizzling-bill-ackman-loves-it-and-these-etfs-do-too">Chipotle&#8217;s Stock Is Sizzling—Bill Ackman Loves It And These ETFs Do Too</a></li>
</ul>
Image: Shutterstock

Broad U.S. Equity ETFs

ETFs

SPX Nosedives 4.5%: Can ETFs Like SPY Weather The Market Storm?

President Trump Says U.S. To Apply 31% Tariff On Imports From Switzerland

Deep-pocketed investors have adopted a bearish approach towards Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CLF usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Cleveland-Cliffs. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 75% bearish. Among these notable options, 3 are puts, totaling $518,986, and 5 are calls, amounting to $317,655.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $4.0 and $27.0 for Cleveland-Cliffs, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Cleveland-Cliffs's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cleveland-Cliffs's whale activity within a strike price range from $4.0 to $27.0 in the last 30 days. 
<h3>Cleveland-Cliffs 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743625857_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CLF</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$18.6</td>
<td>$18.55</td>
<td>$18.6</td>
<td>$27.00</td>
<td>$465.0K</td>
<td>27</td>
<td>0</td>
</tr>
<tr>
<td>CLF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/04/25</td>
<td>$0.42</td>
<td>$0.39</td>
<td>$0.4</td>
<td>$8.00</td>
<td>$100.0K</td>
<td>1.7K</td>
<td>2.6K</td>
</tr>
<tr>
<td>CLF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$4.45</td>
<td>$4.35</td>
<td>$4.45</td>
<td>$4.00</td>
<td>$88.9K</td>
<td>173</td>
<td>200</td>
</tr>
<tr>
<td>CLF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$0.25</td>
<td>$0.23</td>
<td>$0.25</td>
<td>$10.00</td>
<td>$56.5K</td>
<td>3.4K</td>
<td>2.2K</td>
</tr>
<tr>
<td>CLF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.24</td>
<td>$5.00</td>
<td>$42.4K</td>
<td>17</td>
<td>100</td>
</tr>
</tbody>
</table>

<h3>About Cleveland-Cliffs</h3>
Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.
In light of the recent options history for Cleveland-Cliffs, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Cleveland-Cliffs Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 27,172,681, with CLF's price up by 7.78%, positioned at $8.73.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 19 days.</li>
</ul>
<h3>What The Experts Say On Cleveland-Cliffs</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $13.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Seaport Global continues to hold a Buy rating for Cleveland-Cliffs, targeting a price of $11. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Cleveland-Cliffs, which currently sits at a price target of $15. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Cleveland-Cliffs, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Spotlight on Cleveland-Cliffs: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Snowflake.
Looking at options history for Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $429,007 and 6, calls, for a total amount of $1,817,110.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $220.0 for Snowflake over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Snowflake stands at 1199.1, with a total volume reaching 884.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Snowflake, situated within the strike price corridor from $75.0 to $220.0, throughout the last 30 days.
<h3>Snowflake Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743625851_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.85</td>
<td>$8.45</td>
<td>$8.55</td>
<td>$220.00</td>
<td>$1.3M</td>
<td>2.7K</td>
<td align="right">0</td>
</tr>
<tr>
<td>SNOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$12.15</td>
<td>$12.0</td>
<td>$12.0</td>
<td>$130.00</td>
<td>$240.0K</td>
<td>0</td>
<td align="right">202</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$18.2</td>
<td>$17.75</td>
<td>$17.9</td>
<td>$180.00</td>
<td>$178.9K</td>
<td>5.5K</td>
<td align="right">100</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/20/26</td>
<td>$15.9</td>
<td>$15.0</td>
<td>$15.42</td>
<td>$200.00</td>
<td>$154.2K</td>
<td>437</td>
<td align="right">100</td>
</tr>
<tr>
<td>SNOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$2.49</td>
<td>$2.18</td>
<td>$2.3</td>
<td>$75.00</td>
<td>$115.0K</td>
<td>1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Snowflake</h3>
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that went public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to buy and ingest data, while its data solutions can be hosted on various public clouds.
In light of the recent options history for Snowflake, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Snowflake's Current Market Status</h3>
<ul>
<li>With a trading volume of 5,891,638, the price of SNOW is up by 4.32%, reaching $156.0.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 49 days from now.</li>
</ul>
<h3>What The Experts Say On Snowflake</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $198.75.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Jefferies has decided to maintain their Buy rating on Snowflake, which currently sits at a price target of $190. 
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for Snowflake, targeting a price of $210. 
&#x2A; In a cautious move, an analyst from Macquarie downgraded its rating to Neutral, setting a price target of $160. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Snowflake, maintaining a target price of $235. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Snowflake, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Looking At Snowflake's Recent Unusual Options Activity

President Trump Says U.S. To Apply 10% Tariff On Imports From United Kingdom

Deep-pocketed investors have adopted a bullish approach towards McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MCD usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for McDonald's. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 60% leaning bullish and 10% bearish. Among these notable options, 6 are puts, totaling $360,806, and 4 are calls, amounting to $249,741.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $290.0 and $320.0 for McDonald's, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of McDonald's stands at 1078.43, with a total volume reaching 1,719.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in McDonald's, situated within the strike price corridor from $290.0 to $320.0, throughout the last 30 days.
<h3>McDonald's Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743625846_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$40.1</td>
<td>$39.45</td>
<td>$40.0</td>
<td>$290.00</td>
<td>$120.0K</td>
<td>1.5K</td>
<td align="right">30</td>
</tr>
<tr>
<td>MCD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$12.35</td>
<td>$11.95</td>
<td>$12.28</td>
<td>$320.00</td>
<td>$89.9K</td>
<td>2.0K</td>
<td align="right">189</td>
</tr>
<tr>
<td>MCD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$12.3</td>
<td>$12.15</td>
<td>$12.15</td>
<td>$320.00</td>
<td>$88.6K</td>
<td>2.0K</td>
<td align="right">262</td>
</tr>
<tr>
<td>MCD</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$12.35</td>
<td>$12.0</td>
<td>$12.2</td>
<td>$320.00</td>
<td>$71.9K</td>
<td>2.0K</td>
<td align="right">115</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$7.2</td>
<td>$7.0</td>
<td>$7.1</td>
<td>$320.00</td>
<td>$63.9K</td>
<td>351</td>
<td align="right">98</td>
</tr>
</tbody>
</table>

<h3>About McDonald's</h3>
McDonald's is the largest restaurant owner-operator in the world, with 2024 system sales of $131 billion across more than 43,000 stores and 115 markets. McDonald's pioneered the franchise model, building its footprint through partnerships with independent restaurant franchisees and master franchise partners around the globe. The firm earns roughly 60% of its revenue from franchise royalty fees and lease payments, with most of the remainder coming from company-operated stores across its three core segments: the United States, internationally operated markets, and international developmental/licensed markets.
In light of the recent options history for McDonald's, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>McDonald's's Current Market Status</h3>
<ul>
<li>With a volume of 2,731,282, the price of MCD is down -0.65% at $311.58. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 27 days.</li>
</ul>
<h3>What The Experts Say On McDonald's</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $335.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for McDonald's, targeting a price of $335. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for McDonald's with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

This Is What Whales Are Betting On McDonald's

Ever give someone advice, and they circle back later to say it didn't work—only to realize they totally missed the point? That's basically what happened on "<a href="https://youtu.be/IB71eGLmXJc?si=NVoLNMXICj4XZUgz">The Ramsey Show</a>" last week.&nbsp;
A caller phoned in to say she followed Dave Ramsey's Financial Peace University to the letter: she paid off her house, cleared her debts, and ditched credit cards. But now? Her credit score is toast, and her bank says she can't get approved for a store card, let alone finance a used car.
Specifically, she explained that she and her husband wanted to buy a secondhand car but didn't want to drain their cash or retirement funds to do it. So, she figured <a href="https://www.benzinga.com/personal-finance/25/03/44389026/youre-scared-and-you-should-be-dave-ramsey-tells-29-year-old-with-nearly-1-million-of-debt-hes-going-to-destroy-her-life-as-she-knows-it">she'd take out a small loan</a>. That's when the banker hit her with a reality check—her credit score was "really, really low."
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>
Her conclusion? "It didn't work."
Dave's response? Oh, it worked perfectly.
Ramsey didn't hold back. "The goal was to get out of debt, not get back in," he reminded her. He challenged the logic of clawing out of the debt hole only to dive right back in just to appease a bank that—shocker—wants to profit off her borrowing again.
And he had a few choice words for that banker, too. He warned her to stay away from people whose job is to sell debt. "Don't go over there with the snake handlers and expect to get anything but bit by a snake," he said. "He's a freaking banker… His job is to get you into debt."
What really sent her into a tailspin? That mysteriously low credit score. Turns out, when you stop borrowing money and close all your accounts, your credit score eventually drops to zero. That's not a glitch—it's by design. Ramsey clarified that for your score to roll down to zero, every single account has to be closed and carry a zero balance. One lingering collection or open item from years ago, and your score might linger in the 500s instead of vanishing entirely.
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a>
Ramsey's co-host, Jade Warshaw, chimed in with her own story. After she and her husband paid off their debt, she waited eagerly for her score to "roll to zero"—only to be misled by third-party credit sites that hadn't updated the data. Why? Because they make money convincing you to rebuild your score… usually by getting more debt.
Here's the deal: a credit score is a measure of how well you borrow money—not how well you manage it. If you never borrow, your score becomes irrelevant. Ramsey's point is simple: you don't need a credit score if you don't plan on borrowing.
But most people don't know what to do with that idea. The financial system treats a zero credit score like <a href="https://www.benzinga.com/personal-finance/25/01/43085752/its-a-bankers-scam-dave-ramsey-blasts-the-fico-score-system-i-cant-rent-an-apartment-but-i-can-write-a-check-for-the-whole-complex">some kind of digital scarlet letter</a>, but in Ramsey's world, it's a badge of honor.
So, no, the caller's plan didn't fail. It just didn't align with the bank's plan—to get her back on the debt treadmill. As Ramsey put it, if you broke free from a banker who's now urging you to get a secured card "just to build credit," maybe don't take advice from the guy who profits when you stay chained to payments.
See Also: <a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a>
Want a car? Pay cash. Can't afford one right now? Don't buy one. That's the Ramsey gospel, and for those following it faithfully, a zero credit score isn't a problem—it's a milestone.
If your goal was to escape the debt trap, don't panic when you realize you're not playing the credit score game anymore. That just means you won.
<a href="https://www.benzinga.com/personal-finance/24/02/36934103/kevin-o-leary-suggests-everyone-have-a-credit-card-with-a-very-low-credit-limit-of-2-000-plus-on">Not everyone sees credit as the enemy</a>. Some financial experts argue that responsible credit card use can offer rewards, fraud protection, and convenience—especially when bills are paid in full each month. Plenty of people travel-hack their way to free flights and earn cashback on purchases they were going to make anyway.
Still, Ramsey's approach is zero-compromise. He even froze his kids' credit files when they were minors—just to make sure no one, not even future-them, could get lured into debt.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

Personal Finance

Dave Ramsey Caller Tells Him Following Advice To Pay Off House 'Didn't Work' Because Now She Has No Credit — But He Says That Was The Point

Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) has outperformed the market over the past 5 years by 17.89% on an annualized basis producing an average annual return of 34.21%. Currently, Devon Energy has a market capitalization of $24.64 billion. 
Buying $1000 In DVN: If an investor had bought $1000 of DVN stock 5 years ago, it would be worth $4,309.09 today based on a price of $37.99 for DVN at the time of writing.
<h3>Devon Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743625825_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed up 215.32% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 25.00% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 11.41% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 10.93% at $5.10</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 9.39% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 6.65% at $0.61</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 6.06% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 5.85% at $0.18</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 5.82% at $57.96</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 5.03% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.93% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 3.38% at $5.20</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 23.15% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 21.74% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 14.59% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 12.25% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 12.20% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 8.38% at $0.35</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 8.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 6.04% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 5.31% at $0.67</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 4.64% at $1.30</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 3.47% at $0.89</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

BBRRF

CARA

CBDY

CNBX

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CVSI

CWBHF

FFNTF

GBHPF

KAYS

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

MGWFF

MRMD

NWVCF

OILFF

RMHB

SOLCF

XXII

ZDPY

Cannabis Stock Movers For April 2, 2025

President Trump Says U.S. To Apply 32% Tariff On Imports From Taiwan

President Trump Says U.S. To Apply 24% Tariff On Imports From Japan

President Trump Says U.S. To Apply 20% Tariff On Imports From European Union

President Trump Says U.S. To Apply 34% Tariff On Imports From China

President Trump Says We Will Charge Them Half; Says They Won't Be Full Reciprocal

Press Releases

Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024

Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma

Health Care

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial

Earnings

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Aura Biosciences to Participate in Upcoming Investor Conferences

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Comments

Aura Biosciences

Actualités

Dernières nouvelles pour Aura Biosciences (NASDAQ:AURA) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL